Veru Inc
$ 2.31
-5.33%
23 Apr - close price
- Market Cap 39,162,800 USD
- Current Price $ 2.31
- High / Low $ 2.42 / 2.28
- Stock P/E N/A
- Book Value 2.31
- EPS -1.21
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.43 %
- ROE -0.60 %
- 52 Week High 7.40
- 52 Week Low 2.06
About
Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. The company is headquartered in Miami, Florida.
Analyst Target Price
$25.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-11 | 2025-12-01 | 2025-08-12 | 2025-05-06 | 2025-02-06 | 2024-12-05 | 2024-08-08 | 2024-04-01 | 2024-02-14 | 2023-12-08 | 2023-08-10 | 2023-05-11 |
| Reported EPS | -0.26 | 0.09 | -0.5 | -0.0603 | -0.0713 | -0.052 | -0.07 | -0.08 | -0.08 | -0.12 | -0.13 | -0.48 |
| Estimated EPS | -0.47 | -0.0567 | -0.05 | -0.05 | -0.08 | -0.08 | -0.06 | -0.1 | -0.1 | -0.23 | -0.2 | -0.33 |
| Surprise | 0.21 | 0.1467 | -0.45 | -0.0103 | 0.0087 | 0.028 | -0.01 | 0.02 | 0.02 | 0.11 | 0.07 | -0.15 |
| Surprise Percentage | 44.6809% | 258.7302% | -900% | -20.6% | 10.875% | 35% | -16.6667% | 20% | 20% | 47.8261% | 35% | -45.4545% |
Previous Dividend Records
| Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | Jan 1970 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | None | None | None | None | None | None | None | None | None | None |
| Amount | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | $0.06 | $0.06 | $0.06 | $0.06 | $0.05 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: VERU
2026-04-16 04:10:23
This article reports on an SEC filing by VERU INC. (NASDAQ: VERU) regarding a Notice of Effectiveness for an S-3 form. The filing indicates an effectiveness date of April 15, 2026, at 4:00 p.m. and is deemed to have a neutral impact and sentiment.
2026-04-07 20:40:57
Veru Inc. has filed an S-3 Registration Statement to register 23.8 million shares of common stock stemming from warrants issued in October 2025. These include pre-funded warrants, Series A warrants, and Series B warrants, with varied exercise prices and expiration terms. If all warrants are exercised for cash, Veru expects to receive approximately $50.4 million in proceeds.
2026-04-07 20:40:57
Veru Inc. has filed an S-3 shelf registration statement to offer up to $200 million in various securities, including common stock, debt, preferred stock, warrants, purchase contracts, rights, and units. The proceeds are intended for general corporate purposes, including working capital, R&D, clinical trials, and potential acquisitions. Each offering under this shelf will be accompanied by a specific prospectus supplement detailing the terms, pricing, and use of proceeds for that particular sale.
2026-04-04 06:10:46
Veru (NASDAQ: VERU) is anticipating regulatory clarity for its enobosarm Phase 3 trial by the third quarter of 2025. This development follows discussions with the FDA regarding a non-clinical study and the clinical development path for the drug, which is aimed at treating ER+, HER2- metastatic breast cancer. The company has clarified the design of a potential Phase 3 study and indicated that the FDA does not require an additional non-clinical carcinogenicity study.
2026-04-02 10:09:10
This page on Stock Titan provides a comprehensive resource for investors to access Veru (VERU) SEC filings, including 10-K, 10-Q, 8-K, and insider trading forms. It highlights recent events such as capital raising through public offerings, a 1-for-10 reverse stock split, regaining Nasdaq compliance, and settlement of debt obligations. The platform also offers AI-powered summaries and sentiment analysis for each filing to help investors understand the impact of these corporate actions.
2026-03-31 05:10:59
This article provides the current stock price quote and chart for Veru Inc. (VERU). It indicates that the content is available through Capital.com's smart investment app, suggesting access to real-time trading data and tools.
